Clinical Trial Update: Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in People Who Are Overweight or Living With Obesity (OASIS 1) [Phase 3]

View source ↗

Summary

This entry notes the completed Phase 3 OASIS 1 trial evaluating daily oral semaglutide tablets for obesity and overweight.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• oral semaglutide (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Obesity, Overweight | Phase 3 | Status: COMPLETED